![Mogens Winkel Madsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mogens Winkel Madsen
Nessuna posizione attualmente
Storia della carriera di Mogens Winkel Madsen
Precedenti posizioni note di Mogens Winkel Madsen
Società | Posizione | Inizio | Fine |
---|---|---|---|
LiPlasome Pharma A/S
![]() LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Direttore operativo | 27/03/2014 | - |
Direttore Tecnico/Scientifico/R&S | - | 27/03/2014 |
Statistiche
Distribuzione geografica
Danimarca | 2 |
Posizioni
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
LiPlasome Pharma A/S
![]() LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology LiPlasome Pharma A/S develops, produces and supplies drugs for chemotherapy treatment. It has developed a technology based on incapsulation of chemotherapy in liposomes (fatty molecules) that will only dissolve in and around cancer tissue (tumors or metastases). The firm’s technology will improve chemotherapy treatment within a wide range of cancer diseases significantly as it improves the balance between effect and side effects. LiPlasome’s first drug candicate LiplaCis which is a liposonal formulation of Cisplatin, is in clinical phase 1. The company was founded in January 2001 by Ole Gunner Mouritsen and is headquartered in Hoersholm, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Mogens Winkel Madsen
- Esperienza